CRBU
Price
$1.28
Change
-$0.07 (-5.19%)
Updated
Jun 27 closing price
Capitalization
119.05M
45 days until earnings call
LYEL
Price
$8.94
Change
-$0.18 (-1.97%)
Updated
Jun 27 closing price
Capitalization
132.38M
39 days until earnings call
Interact to see
Advertisement

CRBU vs LYEL

Header iconCRBU vs LYEL Comparison
Open Charts CRBU vs LYELBanner chart's image
Caribou Biosciences
Price$1.28
Change-$0.07 (-5.19%)
Volume$12.14M
Capitalization119.05M
Lyell Immunopharma
Price$8.94
Change-$0.18 (-1.97%)
Volume$1.31M
Capitalization132.38M
CRBU vs LYEL Comparison Chart in %
Loading...
CRBU
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LYEL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CRBU vs. LYEL commentary
Jun 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRBU is a Hold and LYEL is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 28, 2025
Stock price -- (CRBU: $1.28 vs. LYEL: $8.94)
Brand notoriety: CRBU and LYEL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRBU: 752% vs. LYEL: 694%
Market capitalization -- CRBU: $119.05M vs. LYEL: $132.38M
CRBU [@Biotechnology] is valued at $119.05M. LYEL’s [@Biotechnology] market capitalization is $132.38M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRBU’s FA Score shows that 1 FA rating(s) are green whileLYEL’s FA Score has 0 green FA rating(s).

  • CRBU’s FA Score: 1 green, 4 red.
  • LYEL’s FA Score: 0 green, 5 red.
According to our system of comparison, CRBU is a better buy in the long-term than LYEL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRBU’s TA Score shows that 4 TA indicator(s) are bullish while LYEL’s TA Score has 3 bullish TA indicator(s).

  • CRBU’s TA Score: 4 bullish, 4 bearish.
  • LYEL’s TA Score: 3 bullish, 7 bearish.
According to our system of comparison, CRBU is a better buy in the short-term than LYEL.

Price Growth

CRBU (@Biotechnology) experienced а -4.48% price change this week, while LYEL (@Biotechnology) price change was +2.88% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.22%. For the same industry, the average monthly price growth was +31.37%, and the average quarterly price growth was +12.88%.

Reported Earning Dates

CRBU is expected to report earnings on Aug 12, 2025.

LYEL is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (+4.22% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LYEL($132M) has a higher market cap than CRBU($119M). CRBU YTD gains are higher at: -19.497 vs. LYEL (-30.156). CRBU has higher annual earnings (EBITDA): -159.14M vs. LYEL (-204.02M). LYEL has more cash in the bank: 301M vs. CRBU (208M). CRBU has less debt than LYEL: CRBU (26.2M) vs LYEL (48.9M). CRBU has higher revenues than LYEL: CRBU (9.92M) vs LYEL (65K).
CRBULYELCRBU / LYEL
Capitalization119M132M90%
EBITDA-159.14M-204.02M78%
Gain YTD-19.497-30.15665%
P/E RatioN/AN/A-
Revenue9.92M65K15,258%
Total Cash208M301M69%
Total Debt26.2M48.9M54%
TECHNICAL ANALYSIS
Technical Analysis
CRBULYEL
RSI
ODDS (%)
Bearish Trend 1 day ago
80%
Bearish Trend 1 day ago
86%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
85%
Bullish Trend 1 day ago
85%
Momentum
ODDS (%)
N/A
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bullish Trend 1 day ago
82%
Bearish Trend 1 day ago
84%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
85%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
86%
Advances
ODDS (%)
Bullish Trend 4 days ago
79%
Bullish Trend 5 days ago
83%
Declines
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
81%
Aroon
ODDS (%)
Bullish Trend 1 day ago
79%
Bearish Trend 6 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
CRBU
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LYEL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
AQGNX11.80N/A
N/A
AQR Global Equity N
RSIPX15.01N/A
N/A
Columbia Disciplined Core Inst2
GSIOX27.40N/A
N/A
Goldman Sachs Small Cap Gr Insghts Instl
RYSVX194.82N/A
N/A
Rydex S&P SmallCap 600 Pure Value A
GOFIX18.12N/A
N/A
GMO Resources III

CRBU and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRBU has been loosely correlated with CRSP. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if CRBU jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRBU
1D Price
Change %
CRBU100%
-5.19%
CRSP - CRBU
60%
Loosely correlated
+1.69%
FATE - CRBU
57%
Loosely correlated
-5.45%
CCCC - CRBU
55%
Loosely correlated
-6.59%
BEAM - CRBU
55%
Loosely correlated
-2.04%
PRME - CRBU
53%
Loosely correlated
-8.68%
More

LYEL and

Correlation & Price change

A.I.dvisor indicates that over the last year, LYEL has been loosely correlated with VCYT. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if LYEL jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LYEL
1D Price
Change %
LYEL100%
-1.97%
VCYT - LYEL
46%
Loosely correlated
+2.13%
CRBU - LYEL
41%
Loosely correlated
-5.19%
TYRA - LYEL
41%
Loosely correlated
-7.12%
ZNTL - LYEL
39%
Loosely correlated
-6.35%
PRME - LYEL
37%
Loosely correlated
-8.68%
More